Skip to content

Investor Relations / SEC Filings

SEC Filings

Filing date Form Filer Description View
SC 13D/A FIL LTD

An amendment to a SC 13D filing

View HTML
SC 13D/A FIL LTD

An amendment to a SC 13D filing

View HTML
SC 13D CORPORATE OPPORTUNITIES FUND LP

Filing by person(s) reporting owned shares of common stock in a public company >5%

View HTML
SC 13D/A ELAN CORP PLC

An amendment to a SC 13D filing

View HTML
SC 13D/A CORPORATE OPPORTUNITIES FUND LP

An amendment to a SC 13D filing

View HTML
SC 13D/A CORPORATE OPPORTUNITIES FUND LP

An amendment to a SC 13D filing

View HTML
6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

View HTML
SC 13G/A

An amendment to the SC 13G filing

View HTML
S-8

Securities offered to employees pursuant to employee benefit plans

View HTML
6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

View HTML

Copyright Morningstar

copyright
© 2018, Amarin Corporation
Privacy policy  |  Disclaimer
Dublin Office
2 Pembroke House, Upper Pembroke
Street 28-32
Dublin 2, Ireland
US Investor Relations
Amarin Pharma Inc.
1430 Route 206
Bedminster, NJ 07921 USA
Telephone:
+1 908 719 1315
Fax:
+1 908 719 3012

Amarin Corporation